Heat Treatment of Amphotericin B Modifies Its Serum Pharmacokinetics, Tissue Distribution, and Renal Toxicity following Administration of a Single Intravenous Dose to Rabbits

Documenti analoghi

• Amphotericin B Lipid Complex or Amphotericin B Multiple-Dose Administration to Rabbits with Elevated Plasma Cholesterol Levels: Pharmacokinetics in Plasma and Blood, Plasma Lipoprotein Levels, Distribution in Tissues, and Renal Toxicities
  di: Ramaswamy, Manisha, et al.
  Pubblicazione: (2001)
• Pharmacokinetics, Distribution in Serum Lipoproteins and Tissues, and Renal Toxicities of Amphotericin B and Amphotericin B Lipid Complex in a Hypercholesterolemic Rabbit Model: Single-Dose Studies
  di: Wasan, Kishor M., et al.
  Pubblicazione: (1998)
• Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration
  di: Hnik, Peter, et al.
  Pubblicazione: (2020)
• Effect of Heat-Treated Amphotericin B on Renal and Fungal Cytotoxicity
  di: Bartlett, Karen, et al.
  Pubblicazione: (2004)
• Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: Studies with cyclosporine A
  di: Wasan, Kishor M., et al.
  Pubblicazione: (2002)